Fallacies Can Hamper Your Returns: Harmony Gold Mining Company Limited (HMY), MetLife, Inc. (MET)

Looking at top Wall Street opinions, Harmony Gold Mining Company Limited (NYSE: HMY) has recently made its way into the research list of JP Morgan – signaling that their analyst’s rating adjustment is noteworthy. This stock was upgraded to a rating of Overweight in the eyes of JP Morgan, whereas its previous rating was Underweight in the eyes of JP Morgan, as reported on Thursday, February 21st, 2019. Another heavy-hitting research note was published by Macquarie on Tuesday August 28th, 2018, with this firm downgrading HMY to an updated rating of Underperform from its previous rating of Neutral. In the past six months and three months of trading, shares of Harmony Gold Mining Company Limited (HMY) have moved by 41.46% and 65.71%, respectively.

Brokerage Updates Related to Harmony Gold Mining Company Limited (HMY) Stock

This publicly-traded organization generated gains of 9.85% over the last 5 sessions. Right now, this stock is the subject of 2 analysts’ evaluations, who – on average – have given this company’s shares a Strong Buy rating. Not a Single analyst have given underperform rating or sell rating, and 1 have given a rating of Buy or better. Based on the 2 stock market experts following this company, the average 12-month price target is $3.19. Moreover, individual price targets range between $2.00-$4.86. With its recent move to $2.48, we can see that these firms project this stock will gain by 76.83% in one year.

Updates from Harmony Gold Mining Company Limited (HMY) SEC Form 4

This particular company’s shares have garnered a lot of attention in recent days, as insiders are unloading their holdings while having generated a 15.10% rise since the beginning of the calendar year.

MetLife, Inc. (NYSE:MET) experienced a gain of 2.81% from the closing price in the previous trading day. That boost the price to $46.85 per share, as observed on January 1st, 1970, at a time when the total trading volume reached 7,371,237 shares of stock – compared to the typical average of 4.55M shares per day (as recorded over the past three months). The consensus estimate for these shares has been shifted to $53.53.

Pricing Indications for MetLife, Inc. (MET)

This organization has had a price-to-earnings ratio of 7.70 in the last year. Meanwhile, it gained 49.08 from its observable 50-day simple moving average. Right at this moment, the per-share value is 3.46% higher than the mean per-share price over the last 200 days in the market.

MetLife, Inc. (NYSE:MET) In-Depth Brokerage Insights

We can see that a number of brokerage firms are putting their focus onto this stock. Out of this group, 1 have a sell rating, 5 have a Buy rating, 5 have an outperform rating, while 8 provided a Hold rating for these shares – thanks to data from Thomson Reuters I/B/E/S. Additionally, 0 have recommended that these shares are an Underperforming investment. The current consensus recommendation is at 2.40, based on information from Thomson Reuters.

MET Stock Value Potential

In trading activity as of late, this stock’s value was 45.29 up from its 200 day moving average, while also -4.58% down when compared against its 50-day simple moving average. Over the course of the past year of trading, the share price stuck in the range of $42.00-$63.00. The market value for the entire organization reached 45.50B. In the last trading session, the price ended the day at $45.57. The institutional holdings related to this organization account for 0.10%, and the Beta factor is now 1.09. This company’s RSI (Relative Strength Index) managed to hit 34.71.

MetLife, Inc. (NYSE:MET) Analyst Points of Focus

MetLife, Inc. (MET) has found itself inside of Evercore ISI’s research list, so their analyst rating adjustment is worth taking note of. This stock was downgraded to In-line, compared to its previous rating of Outperform by Evercore ISI, as garnered from a news report on Tuesday July 16th, 2019. An additional helpful research note was sent out by Sandler O’Neill’s on Tuesday March 19th, 2019. The brokerage decided to downgrade MET to Hold from its previous rating of Buy.